1. Adams, J. M. and Cory, S. (2002). Apoptosomes: engines for caspase activation. Curr Opin Cell Biol 14, 715–720.
2. Adida, C., Haioun, C., Gaulard, P., Lepage, E., Morel, P., Briere, J., Dombret, H., Reyes, F., Diebold, J., Gisselbrecht, C., et al. (2000). Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96, 1921–1925.
3. Alderson, R. F., Birse, C. E., Connolly, K., Humphreys, R. C., Choi, G. H., Fox, N. L., Gilles Gallant, Ina Han, Ron Johnson, et al. (2003). TRAIL-R2 mAb, a human agonistic monoclonal antibody to tumor necrosis factor-related apoptosis inducing ligand receptor 2, induces apoptosis in human tumor cells. Proceedings of 94th AACR Annual Meeting 44, 963.
4. Amantana, A., London, C. A., Iversen, P. L., and Devi, G. R. (2004). X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 3, 699–707.
5. Arai, T., Akiyama, Y., Okabe, S., Saito, K., Iwai, T., and Yuasa, Y. (1998). Genomic organization and mutation analyses of the DR5/TRAIL receptor 2 gene in colorectal carcinomas. Cancer Lett 133, 197–204.